Temporal mechanisms of myogenic specification in human induced pluripotent stem cells

被引:4
作者
Nayak, P. [1 ]
Colas, A. [2 ]
Mercola, M. [3 ,4 ]
Varghese, S. [5 ]
Subramaniam, S. [1 ]
机构
[1] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA
[2] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA
[3] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[5] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA
关键词
SELF-RENEWAL; IN-VIVO; MUSCLE; DIFFERENTIATION; ENRICHR; NANOG; ZIC3; EXIT;
D O I
10.1126/sciadv.abf7412
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Understanding the mechanisms of myogenesis in human induced pluripotent stem cells (hiPSCs) is a prerequisite to achieving patient-specific therapy for diseases of skeletal muscle. hiPSCs of different origin show distinctive kinetics and ability to differentiate into myocytes. To address the unique cellular and temporal context of hiPSC differentiation, we perform a longitudinal comparison of the transcriptomic profiles of three hiPSC lines that display differential myogenic specification, one robust and two blunted. We detail temporal differences in mechanisms that lead to robust myogenic specification. We show gene expression signatures of putative cell subpopulations and extracellular matrix components that may support myogenesis. Furthermore, we show that targeted knockdown of ZIC3 at the outset of differentiation leads to improved myogenic specification in blunted hiPSC lines. Our study suggests that.-catenin transcriptional cofactors mediate cross-talk between multiple cellular processes and exogenous cues to facilitate specification of hiPSCs to mesoderm lineage, leading to robust myogenesis.
引用
收藏
页数:12
相关论文
共 55 条
[51]   In Vivo Human Somitogenesis Guides Somite Development from hPSCs [J].
Xi, Haibin ;
Fujiwara, Wakana ;
Gonzalez, Karen ;
Jan, Majib ;
Liebscher, Simone ;
Van Handel, Ben ;
Schenke-Layland, Katja ;
Pyle, April D. .
CELL REPORTS, 2017, 18 (06) :1573-1585
[52]   A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells [J].
Young, Courtney S. ;
Hicks, Michael R. ;
Ermolova, Natalia V. ;
Nakano, Haruko ;
Jan, Majib ;
Younesi, Shahab ;
Karumbayaram, Saravanan ;
Kumagai-Cresse, Chino ;
Wang, Derek ;
Zack, Jerome A. ;
Kohn, Donald B. ;
Nakano, Atsushi ;
Nelson, Stanley F. ;
Miceli, M. Carrie ;
Spencer, Melissa J. ;
Pyle, April D. .
CELL STEM CELL, 2016, 18 (04) :533-540
[53]   Metabolic Regulation in Pluripotent Stem Cells during Reprogramming and Self-Renewal [J].
Zhang, Jin ;
Nuebel, Esther ;
Daley, George Q. ;
Koehler, Carla M. ;
Teitell, Michael A. .
CELL STEM CELL, 2012, 11 (05) :589-595
[54]   PRC2 Complexes with JARID2, MTF2, and esPRC2p48 in ES Cells to Modulate ES Cell Pluripotency and Somatic Cell Reprograming [J].
Zhang, Zhuo ;
Jones, Amanda ;
Sun, Chiao-Wang ;
Li, Chao ;
Chang, Chia-Wei ;
Joo, Heui-Yun ;
Dai, Qian ;
Mysliwiec, Matthew R. ;
Wu, Li-Chen ;
Guo, Yahong ;
Yang, Wei ;
Liu, Kaimao ;
Pawlik, Kevin M. ;
Erdjument-Bromage, Hediye ;
Tempst, Paul ;
Lee, Youngsook ;
Min, Jinrong ;
Townes, Tim M. ;
Wang, Hengbin .
STEM CELLS, 2011, 29 (02) :229-240
[55]   β-Catenin/Tcf7l2-dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer [J].
Zhao, Zibo ;
Wang, Lu ;
Bartom, Elizabeth ;
Marshall, Stacy ;
Rendleman, Emily ;
Ryan, Caila ;
Shilati, Anthony ;
Savas, Jeffrey ;
Chandel, Navdeep ;
Shilatifard, Ali .
SCIENCE ADVANCES, 2019, 5 (07)